RANI
Rani Therapeutics Holdings Inc.
$2.20
+$0.75(+51.72%)
53
Overall
40
Value
66
Tech
--
Quality
Market Cap
$24.66M
Volume
60.96M
52W Range
$0.39 - $3.87
Target Price
$9.00
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $2.7M | -- | -- | $1.0M | ||
| Total Revenue | $2.7M | -- | -- | $1.0M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $2.7M | -- | -- | $1.0M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $54.3M | $63.5M | $66.1M | $54.3M | ||
| Research & Development | $26.5M | $36.6M | $39.6M | $26.7M | ||
| Research Expense | $26.5M | $36.6M | $39.6M | $26.7M | ||
| Selling, General & Administrative | $27.8M | $26.8M | $26.5M | $23.9M | ||
| General & Administrative Expenses | $27.8M | $26.8M | $26.5M | $23.9M | ||
| Salaries & Wages | $22.6M | $15.8M | $19.0M | $16.0M | ||
| Depreciation & Amortization | $500.0K | $500.0K | $800.0K | $1.0M | ||
| Depreciation & Amortization | $500.0K | $500.0K | $800.0K | $1.0M | ||
| Other Operating Expenses | $-254.0K | $-222.0K | $-260.0K | $-162.0K | ||
| OPERATING INCOME | ||||||
| Operating income | $-51.6M | $-63.5M | $-66.1M | $-53.3M | ||
| EBITDA | $-52.1M | $-61.7M | $-60.7M | $-48.5M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $466.0K | $1.1M | $5.1M | $5.0M | ||
| Intinc | $89.0K | $1.2M | $3.3M | $1.8M | ||
| Net Non-Operating Interest Income/Expense | $-377.0K | $177.0K | $-1.8M | $-3.3M | ||
| Other Income/Expense | $-329.0K | -- | -- | $-5.0K | ||
| Other Special Charges | $329.0K | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||
| Special Income Charges | -- | -- | -- | $-3.7M | ||
| Impairment of Capital Assets | -- | -- | -- | $3.7M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-52.6M | $-62.2M | $-62.8M | $-51.6M | ||
| Pre-Tax Income | $-53.0M | $-63.3M | $-67.9M | $-56.6M | ||
| INCOME TAX | ||||||
| Tax Provision | $41.0K | $70.0K | -- | -- | ||
| NET INCOME | ||||||
| Net Income | $-8.3M | $-30.6M | $-34.0M | $-30.0M | ||
| Net Income (Continuing Operations) | $-8.3M | $-63.3M | $-67.9M | $-56.6M | ||
| Net Income (Discontinued Operations) | $-8.3M | $-30.6M | $-34.0M | $-30.0M | ||
| Net Income (Common Stockholders) | $-6.9M | $-30.6M | $-34.0M | $-30.0M | ||
| Normalized Income | $-41.9M | -- | -- | $-52.3M | ||
| TOTALS | ||||||
| Total Expenses | $54.3M | $63.5M | $66.1M | $54.3M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $19.5M | $23.8K | $25.5K | $28.5K | ||
| Average Shares Outstanding (Diluted) | -- | $23.8K | $25.5K | $28.5K | ||
| Shares Outstanding | $49.2M | $49.4M | $47.9M | $57.5M | ||
| Basic EPS | $-0.43 | $-1.28 | $-1.33 | $-1.05 | ||
| Basic EPS (Continuing Operations) | $-0.43 | $-1.28 | $-1.33 | $-1.05 | ||
| Diluted EPS | $-0.43 | $-1.28 | $-1.33 | $-1.05 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.28 | $-1.33 | $-1.05 | ||
| OTHER METRICS | ||||||
| Minority Interests | $44.8M | $32.8M | $33.9M | $26.6M | ||
| Other Gand A | $27.8M | $26.8M | $26.5M | $23.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RANI | $2.20 | +51.7% | 60.96M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rani Therapeutics Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW